Researchers at the Netherlands Institute for Neuroscience have identified a link between myelin sheath degradation and abnormal brain activity during sleep, potentially providing a new non-invasive biomarker for neurodegenerative diseases. According to research presented at the Federation of European Neuroscience Societies (FENS) Forum 2026, myelin damage triggers epilepsy-like electrical spikes and disrupts critical oscillations exclusively during sleep, offering a window into early disease progression for conditions like multiple sclerosis (MS) and Alzheimer’s disease.
The Sleep-Locked Spike Phenomenon
Dr. Mohit Dubey, a ZonMw Memorable Dementia Fellow at the Netherlands Institute for Neuroscience, utilized multi-night EEG recordings to track brain activity in mouse models with myelin damage. The data revealed distinct, abnormal electrical spikes that mirror those observed in clinical epilepsy or advanced Alzheimer’s patients. These spikes are not constant; they emerge only during sleep.
The research suggests that the myelin sheath—the insulating layer essential for signal efficiency—acts as a stabilizer for neural networks. When this insulation breaks down, the brain’s internal electrical pathways fail to manage the rhythmic demands of sleep, resulting in erratic spikes that remain hidden while the patient is awake.
Myelin Decay and REM Sleep Fragmentation
Beyond NREM sleep abnormalities, the study documented a slowing of electrical rhythms during rapid eye movement (REM) sleep. REM sleep is critical for dreaming and the “replay” of daytime experiences, a process that relies on rhythmic electrical oscillations to coordinate communication between distant neurons.
Dr. Dubey noted that when myelin degenerates, these oscillations become sluggish and fragmented. This disruption correlates with the cognitive decline and fatigue often reported by patients with MS and Alzheimer’s. By comparing mouse models with clinical EEG data from MS patients, the research team established that these sleep-state failures are a direct consequence of structural circuit instability caused by myelin loss.
Sleep Recordings as Early Diagnostic Biomarkers
One of the primary challenges in treating neurodegenerative diseases is the “silent” period where structural damage occurs long before physical symptoms appear. Because these electrical signatures track precisely with myelin health, overnight sleep monitoring could eventually function as a non-invasive early-warning system.
Professor Christina Dalla of the National and Kapodistrian University of Athens, who serves as chair of the FENS Forum communication committee, noted that these findings highlight the potential of sleep architecture as both a diagnostic tool and a future therapeutic target. While current treatments for MS focus on modulating the immune system to prevent further myelin attack, there are currently no approved therapies to actively repair existing damage. Understanding the link between sleep rhythms and myelin health could guide the development of future interventions aimed at stimulating repair during rest cycles.
Frequently Asked Questions
Why do these electrical spikes occur only during sleep?
According to Dr. Dubey, the brain is flooded with sensory input and conscious control during wakefulness, which keeps neural networks regulated. During sleep, the brain relies on synchronized, rhythmic oscillations; when myelin is damaged, the circuits short-circuit under the pressure of these rhythms, causing spikes to emerge.
How does this impact memory?
Sleep spindles are essential for consolidating daytime experiences into long-term memory. When abnormal spikes “ride” on these spindles due to myelin decay, the brain’s memory-saving routine is systematically disrupted, contributing to the forgetfulness associated with Alzheimer’s.
Is this research applicable to humans?
The current findings are based on mouse models and comparative EEG data from MS patients. While the study provides a strong biological basis for the link between myelin and sleep, further research is required to translate these findings into standardized clinical diagnostic protocols for humans.
Are you interested in the latest breakthroughs in neuroscience? Subscribe to our newsletter for weekly updates on how researchers are mapping the brain and developing new diagnostic tools.